Skip to main content

Universal Registration Document 2019

This Universal Registration Document has been filed on February 17, 2020, with the AMF, as competent authority under Regulation (EU) 2017/1129, without prior approval pursuant to Article 9 of the said regulation.

The Universal Registration Document may be used for the purposes of an offer to the public of securities or admission of securities to trading on a regulated market if completed by a securities note and, if applicable, a summary and any amendments to the Universal Registration Document. The whole is approved by the AMF in accordance with Regulation (EU) 2017/1129.

This Universal Registration Document incorporates by reference the preceding Reference Documents D.19 - 0060 filed on February 18, 2019, and D.18 - 0041 filed on February 20, 2018.

The following information is included by reference in the present Universal Registration Document:

  • The year 2018 consolidated financial statements of Sartorius Stedim Biotech prepared using inter– national accounting standards and the report of the statutory auditors relating to these statements, and the Group 2018 management report appearing on pages 90 to 137 and 18 to 56 respectively, of the Reference Document filed with the Autorité des Marchés Financiers on 19 February 2019, under the number D.19 - 0060.
  • The year 2017 consolidated financial statements of Sartorius Stedim Biotech prepared using inter– national accounting standards and the report of the statutory auditors relating to these statements, and the Group 2017 management report appearing on pages 114 to 161 and 18 to 78 respectively, of the Reference Document filed with the Autorité des Marchés Financiers on 20 February 2018, under the number D.18 - 0041.

The sections of these documents not included are not of interest to an investor, and are covered in another part of this Universal Registration Document.

Copies of the present Universal Registration Document can be obtained from the following: